Weighing the Suitability of a Functional Service Provider (FSP) Model for Clinical Trials
Clinical and regulatory teams face increased pressure to drive uninterrupted progress across the...
Posts about
Regulatory Submissions (9)
Laying the Groundwork to Measure the Impact of Decentralized Clinical Trials (DCTs)
The Tufts CSDD Roundtable took place in November, and on behalf of Veristat, I was honored to...
On-Demand Webinar: Orphan Drug Designation - The Considerations, The Rewards, and How They Differ Between The US and Europe
Did you know approximately 1 in 10 Americans are affected by a rare disease or condition according...
Regulatory Guidance Monthly Review - September 2022
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - August 2022
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Planning the Way Forward for a New Tumor Evaluation Modality
RECIST (Response Evaluation Criteria in Solid Tumors) guidelines were introduced over twenty years...
Regulatory Guidance Monthly Review - July 2022
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - June 2022
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory Guidance Monthly Review - May 2022
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Regulatory TOPRA Webinar: Latest Regulatory Experiences
Each year, Veristat regulatory experts present timely, relevant topics to members of The...